Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
thioredoxin reductase | 7 | 0 | 0 | 7 |
aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
IDH1 | 7 | 0 | 0 | 7 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 4 | 1 | 5 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 7 | 0 | 0 | 7 |
Chain B, HADH2 protein | 7 | 0 | 0 | 7 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
Thymidine kinase | 0 | 3 | 0 | 3 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
GLS protein | 6 | 0 | 0 | 6 |
TDP1 protein | 17 | 0 | 0 | 17 |
Smad3 | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
arylsulfatase A | 7 | 0 | 0 | 7 |
euchromatic histone-lysine N-methyltransferase 2 | 15 | 0 | 0 | 15 |
activating transcription factor 6 | 5 | 0 | 0 | 5 |
Histone H2A.x | 5 | 0 | 0 | 5 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 11 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 17 | 0 | 17 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 3 | 0 | 5 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 6 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
Thymidine kinase | 0 | 2 | 0 | 2 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 13 | 0 | 0 | 13 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
AR protein | 22 | 0 | 0 | 22 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
progesterone receptor | 12 | 0 | 0 | 12 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 15 | 0 | 0 | 15 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
estrogen nuclear receptor alpha | 22 | 0 | 0 | 22 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
polyprotein | 3 | 0 | 0 | 3 |
67.9K protein | 4 | 0 | 0 | 4 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 7 | 0 | 0 | 7 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
Caspase-7 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
caspase-3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
heat shock protein beta-1 | 5 | 0 | 0 | 5 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
geminin | 16 | 0 | 0 | 16 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Polycomb protein EED | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Interferon beta | 9 | 0 | 0 | 9 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 0 | 2 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 0 | 6 |
Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 0 | 6 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
Histamine H2 receptor | 0 | 5 | 2 | 7 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
Substance-P receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 11 | 2 | 13 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 3 | 0 | 1 | 6 |
5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
Spike glycoprotein | 4 | 0 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 1 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 5 | 0 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
Ataxin-2 | 12 | 0 | 0 | 12 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
Histamine H4 receptor | 0 | 4 | 2 | 6 |
Heparanase | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
interleukin 8 | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
G | 5 | 0 | 0 | 5 |
P53 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
Protein-arginine deiminase type-4 | 0 | 4 | 0 | 4 |
cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
pregnane X receptor | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 14 | 3 | 22 |
Glycine receptor subunit alpha-1 | 0 | 14 | 0 | 14 |
Glycine receptor subunit beta | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-2 | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-3 | 0 | 14 | 0 | 14 |
ORF73 | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 2 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 2 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
endonuclease IV | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 4 | 7 |
Histamine H3 receptor | 0 | 1 | 0 | 3 |
Luciferase | 3 | 0 | 0 | 3 |
Thrombopoietin | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 4 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Androgen receptor | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 2 | 0 | 2 |
Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Ubiquitin carboxyl-terminal hydrolase 2 | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Ileal sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Bile acid receptor | 0 | 0 | 1 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Valacyclovir hydrolase | 0 | 0 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
RNA-directed RNA polymerase | 0 | 1 | 1 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |